Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Bimatoprost may help treat hair loss from alopecia areata.

The supplement aims to improve care for children with alopecia areata.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Oral baricitinib is effective and safe for treating alopecia areata.

The document focused on hair disorders, especially alopecia, and discussed treatments and impacts on quality of life.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

AGA patients have a lower quality of life than AA patients.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Inflammatory diets may increase the risk and severity of alopecia areata.

Pediatric hair loss requires personalized treatment based on cause and severity, with specialist support.

Targeting IL-15 may help treat Alopecia Areata.

Yellow dots are common in severe alopecia areata.

SII is a useful and affordable tool to assess and monitor alopecia areata.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Winter-onset alopecia areata patients are more likely to regrow hair within a year compared to spring-onset patients.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Alopecia areata in elderly people is usually mild and responds well to treatment.

Poliosis is common in severe alopecia areata but doesn't significantly affect overall prognosis.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Alopecia areata is a skin condition causing hair loss, and its exact cause is unknown, but it may involve biological mechanisms.

Calcipotriol cream can effectively and safely treat mild-to-moderate patchy hair loss.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Alopecia areata significantly affects mental health, especially in women and those with severe cases.

Severe pediatric alopecia areata worsens quality of life for patients and families.

Wigs significantly improve the well-being of people with severe hair loss.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.